Biogen Idec put itself up for sale last year, but the recalcitrant management found clever ways to make the bidding process so onerous and unattractive that nobody made a bid for it.
In March, Roche and Biogen Idec filed an application with the U.S. Food and Drug Administration seeking expanded approval of Rituxan as reflected in the study's findings.
三月份,罗氏和生物基因艾迪克就研究中的新发现向美国食品药品监督管理局(Foodand Drug Administration)提出新应用的申请。